Abstract
Vasospasm is a common sequela of aneurysmal subarachnoid hemorrhage (SAH). Early surgery and cisternal irrigation facilitate care of the patient in vasospasm, but meticulous attention to the details and timing of interventions is critical, and care must be highly individualized. The incidence of aneurysmal SAH is 6–16 per 100,000 population, and angiographic vasospasm is seen in about 75% of such patients, generally between days 4 and 10 following SAH [1–4]. Symptomatic vasospasm is seen in about 30% of cases [5].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Kassell NF, Torner JC, Haley EC, et al (1990) The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: Overall management results. J Neurosurgery 73: 18 – 36
Drake CG (1981) Progress in cerebrovascular disease. Management of cerebral aneurysm. Stroke 12: 273 – 283
Phillips LH 2d, Whisnant JP, O’Fallon WM, et al (1980) The unchanging pattern of subarachnoid hemorrhage in a community. Neurology 30: 1034 – 1040
Weir B (ed) (1987) Aneurysms Affecting the Nervous System, Baltimore, Williams and Wilkins
Mayberg M (1996) Intracranial arterial spasm. In: Neurosurgery ( 2nd edition ), New York, McGraw-Hill, pp 2245 – 2254
Fisher CM, Kistler JP, Davis JM (1980) Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 6 (1): 1 – 9
Kassell NF, Helm G, Simmons N, et al (1992) Treatment of cerebral vasospasm with intraarterial papaverine. J Neurosurgery 77: 848 – 852
Clouston JE, Numaguchi Y, Zoarski GH, et al (1995) Intraarterial papaverine infusion for cerebral vasospasm after subarachnoid hemorrhage. AJNR: Am J Neuroradiol 16: 27 – 38
Dion JE, Mathis JM, Vinuela F (1996) Endovascular Treatment of Cervicocerebral Aneurysms. In: Wilkins and Rengachary (eds) Neurosurgery, 2nd ed. McGraw-Hill Inc., New York, pp 2383 – 2403
McAuliffe W, Tounsend M, Eskridge JM, et al (1995) Intracranial pressure changes during papavrine infusion for vasospasm. J Neurosurg 83: 426 – 429
Eskridge JM, Newell DW, Winn HR (1994) Endovascular treatment of vasospasm. In: Advances in Neuroembolization Neurosurgery Clinics North America, WB Saunders, Philadelphia, PA, pp 437 – 448
Eskridge JM, McAuliffe W, Song J, et al. Treatment of vasospasm: results of first 50 patients. Neurosurgery (in press)
Eskridge JM (unpublished data)
Findlay JM, Weir BK, Steinke D, et al (1988) Effect of intrathecal thrombolytic therapy on subarachnoid clot and chronic vasospasm in a primate model of SAH. J Neurosurg 69: 723 – 735
Findlay JM, Weir BK, Gordon P, et al (1989) Safety and efficacy of intrathecal thrombolytic in a primate model of cerebral vasospasm. Neurosurg 24:4: 491 – 498
Findlay JM, Weir BK, Kassell NF, et al (1991) Intracisternal recombinant tissue plasminogen activator after aneurysmal subarachnoid hemorrhage. J Neurosurg 75: 181 – 188
Kinugasa K, Kamata I, Hirotsune N, et al (1995) Early treatment of subarachnoid hemorrhage after preventing rerupture of an aneurysm. J Neurosurg 83: 34 – 41
Ohman J, Servo A, Heisdanen O (1991) Effect of intrathecal fibrinolytic therapy on clot lysis and vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 75: 197 – 201
Stolke D, Seifert V (1992) Single intracisternal bolus of recombinant tissue plasminogen activator in patients with aneurysmal subarachnoid hemorrhage: preliminary assessment of efficacy and safety in an open clinical study. 30: 6: 877 – 881
Sasali T, Ohta T, Kikuchi H, et al (1994) A Phase II clinical trial of recombinant human tissue- type plasminogen activaator against cerebaral vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery 35:4: 597 – 605
Seifert V, Zimmermann M, Feldges A (1994) Prevention of delayed ischaemic deficits after aneurysmal subarachnoid haemorrhage by intrathecal bolus injection of tissue plasminogen activator (rTPA). Acta Neurochir 128: 137 – 143
Sano K, Takakura K, Kassell N, et al (1990) Proceeding of the IVth Internatonal Conference on Cerebral Vasospasm (Chapter 10). In: Cerebral Vasospasm, University Of Tokyo Press, Tokyo, pp 292 – 296
Zabramski J, Spetzler R, Lee KS, et al (1991) Phase I trial of plasminogen activator for the prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 75: 189 – 196
Mizoi K, Yoshimoto T, Takahashi A et al (1993) Prospective study on the prevention of cerebral vasospasm by intrathecal fibrinolytic therapy with tissue-type plasminogen activator. J Neurosurg 78: 430 – 437
Usui M, Saito N, Hoya K, et al (1994) Vasospasm prevention with postoperative intrathecal thrombolytic therapy: a retrospective comparison of urokinase, tissue plasminogen activator, and cisternal drainage alone. Neurosurgery 34:2: 235 – 245
Collins R, Peto R, MacMahon S, et al (1990) Blood pressure, stroke, and coronary heart disease Part 2. Short-term reductions in blood pressures: overview of randomized drug trials in their epidemiologic context. Lancet 335: 827 – 838
Lanzino G, Kassell N, Germanson T, et al (1993) Plasma glucose levels and outcome after subarachnoid hemorrhage. J Neurosurg 79: 885 – 891
Sahs AL, Nibbelink DW, Torner JC, et al (eds) (1981) Aneurysmal Subarachnoid Hemorrhage. Report of the Cooperative Study. Baltimore, Urban and Schwarzenberg
Kassell NF, Haley EC, Torner JC (1986) Antifibrinolytic therapy in the treatment of aneurysmal subarachnoid hemorrhage. Current Neurosurgery 33: 137 – 145
Kassell NF, Torner JC, Haley EC, Jane JA, et al (1990) The international cooperative study on the timing of aneurysm surgery. II. Surgical results. J Neurosurgery 73: 37 – 47
Barker F, Ogilvy C (1996) Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: a meta-analysis. J Neurosurg 84: 405 – 414
Haley E, Kassell N, Torner J (1993) A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. J Neurosurg 78: 537 – 547
Kassell N, Haley E, Aperson-Hansen C, et al (1996) Randomized double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a comparative study in Europe, Australasia, and New Zealand. J Neurosurg 84: 221 – 228
Ingall T, Whisnant J, Wiebers D, et al (1989) Has there been a decline in subarachnoid hemorrhage mortality? Stroke 20: 718 – 724
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Wecht, D., Eskridge, J., Findlay, M., Torner, J. (1998). Vasospasm Following Subarachnoid Hemorrhage: Medical and Transvascular Treatment. In: Steiner, T., Hacke, W., Hanley, D.F. (eds) Stroke. Update in Intensive Care and Emergency Medicine, vol 27. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60264-1_17
Download citation
DOI: https://doi.org/10.1007/978-3-642-60264-1_17
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64326-2
Online ISBN: 978-3-642-60264-1
eBook Packages: Springer Book Archive